Joseph Hwang

Joseph Hwang serves as a Territory Manager at Deciphera Pharmaceuticals, focusing on oncology and rare sarcoma since July 2022, specifically on Qinlock, a kinase inhibitor for GIST. Prior to this role, Joseph Hwang was an Oncology Account Manager at GSK from December 2019 to July 2022, working with Zejula and Jemperli for ovarian and endometrial cancers, respectively. Joseph Hwang's career includes significant achievements at Gilead Sciences as a Senior Therapeutic Specialist in the Liver Division from January 2010 to December 2019, where awards included the 2011 President's Club Winner and the 2019 Director's Award. Earlier career highlights include recognition as a Gold Cup Winner and Platinum Performance Award recipient at Daiichi Sankyo from June 2007 to January 2010, and being named the 2007 Trimester 1 Representative of Distinction at Cardinal Health. Joseph Hwang's career commenced as a Territory Manager at Copy Solutions, Inc. from June 2005 to April 2006. Education was completed at UCLA.